Dolutegravir: advancing ethical research in pregnancy

Lancet. 2019 Nov 30;394(10213):1972-1974. doi: 10.1016/S0140-6736(19)32638-8.
No abstract available

MeSH terms

  • Biomedical Research / ethics*
  • Female
  • HIV Infections / drug therapy
  • HIV Integrase Inhibitors / adverse effects*
  • Heterocyclic Compounds, 3-Ring / adverse effects*
  • Humans
  • Oxazines
  • Patient Selection / ethics
  • Piperazines
  • Pregnancy
  • Pregnant People*
  • Prenatal Exposure Delayed Effects / diagnosis
  • Pyridones

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir